Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-019008

EVP, Chief Financial Officer gave up 9,945 shares (to pay taxes)

  • EVP, Chief Financial Officer acquired 18,740 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mueller Brian · EVP, Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-13 Shares withheld for taxes : show line 1 in the form −9,945 $58.51 $581,882 106,691 D
2026-03-16 Grant or award : show line 2 in the form +18,740 125,431 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-16 Grant or award : show line 3 in the form Stock Option (Right to Buy Common Stock) +44,600 44,600 D
Loading xslF345X05/wk-form4_1773794751.xml…